During the corresponding time, Haemonetics Corporation recorded a revenue increase by 5.65 % year on year, sequentially revenue fell by -2.26 %. While revenue at the Haemonetics Corporation's corporate clients
Haemonetics's Comment on Sales, Marketing and Customers
The company serves customers in the Blood Center and Hospital segments. The Blood Center segment includes blood collection and processing devices and disposables for plasma, red cells, and platelets. The Hospital segment comprises Interventional Technologies, which includes Vascular Closure, Sensor-Guided Technologies, and Esophageal Protection product lines, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage, and Transfusion Management product lines. The Plasma business offers automated plasma collection systems, donor management software, and supporting software solutions for plasma collection centers. The company serves the plasma market for fractionation, encompassing plasma used for transfusions and plasma processed into pharmaceuticals. Plasma for transfusion is primarily collected by blood centers, while source plasma for pharmaceuticals is mainly collected by vertically integrated biopharmaceutical companies. The company addresses the plasma processed into pharmaceuticals market primarily through its Plasma business and the transfusion plasma market through its Blood Center business. Plasma collection methods include whole blood donations, apheresis procedures collecting another blood component, and dedicated apheresis procedures collecting only plasma.
Haemonetics’s Comment on Sales, Marketing and Customers
The company serves customers in the Blood Center and Hospital segments. The Blood Center segment includes blood collection and processing devices and disposables for plasma, red cells, and platelets. The Hospital segment comprises Interventional Technologies, which includes Vascular Closure, Sensor-Guided Technologies, and Esophageal Protection product lines, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage, and Transfusion Management product lines. The Plasma business offers automated plasma collection systems, donor management software, and supporting software solutions for plasma collection centers. The company serves the plasma market for fractionation, encompassing plasma used for transfusions and plasma processed into pharmaceuticals. Plasma for transfusion is primarily collected by blood centers, while source plasma for pharmaceuticals is mainly collected by vertically integrated biopharmaceutical companies. The company addresses the plasma processed into pharmaceuticals market primarily through its Plasma business and the transfusion plasma market through its Blood Center business. Plasma collection methods include whole blood donations, apheresis procedures collecting another blood component, and dedicated apheresis procedures collecting only plasma.
Sources:
Haemonetics Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Haemonetics Corporation’s corporate clients.
For your research, we’ve provided 9 tables on Haemonetics Corporation corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
56.37 %